OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC with a contract valued at $50.80 under the delivery order SPE2DX25D9900, with the award posted on July 9, 2026. The contract pertains to the procurement of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505016247068 and PR 7017453920, for federal use. The awardee, identified by CAGE code 1UNB0, is fulfilling this requirement as part of the Department of Defense’s supply chain. The contract does not specify a set-aside type or NAICS code, and no physical office or point of contact details are provided. The award is processed through the DIBBS system with a direct link to the delivery order record, indicating a streamlined procurement process under federal contracting guidelines.
General Info
Agency
Contract Value
$50.8NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
